"Our thoughts are with our colleagues, our patients and the community as we rebuild from this weather incident."īut a Pfizer spokesperson refuted the post's claim that the facility was filled with COVID-19 vaccines. "We are assessing the situation to determine the impact on production," one of the company's tweets says. In a series of tweets, Pfizer confirmed the facility, which is about 60 miles east of Raleigh, was damaged by the tornado and said workers there were able to safely evacuate. Pfizer facility damaged, but COVID-19 vaccines not affectedĪ tornado swept across about a 16-mile stretch of North Carolina on July 19, severely damaging Pfizer's Rocky Mount manufacturing site, as USA TODAY previously reported. ![]() However, the COVID-19 vaccine was never manufactured or stored at the site. ![]() Pfizer's Rocky Mount facility in North Carolina was severely damaged in a recent tornado. Similar posts were also shared on Facebook.įollow us on Facebook! Like our page to get updates throughout the day on our latest debunks Our rating: False The post was retweeted 17,000 times in two days and shared more than 600 times on Facebook, according to CrowdTangle, a social media analytics tool. "BREAKING NEWS: A Pfizer Warehouse Full of Covid Vaccines Was Just DESTROYED BY A TORNADO in North Carolina," reads the post. The Agency provides guidance and advice on the evidence required to support and expedite applications to add new sites or increase the capacity of existing sites for the manufacture of high-quality COVID-19 vaccines.Watch Video: Tornado damages Pfizer facility in North Carolina The claim: North Carolina tornado destroyed Pfizer warehouse full of COVID-19 vaccinesĪ July 19 Twitter post ( direct link, archive link) shows a short clip of a collapsed industrial building damaged by a storm. The changes described will be included in the publicly available information on this vaccine on EMA’s website.ĮMA is in continuous dialogue with all marketing authorisation holders of COVID-19 vaccines as they seek to expand their production capacity for the supply of vaccines in the EU. The new line will enable an increase in finished product fill activities, to synchronize with the active substance scale-up process at the active substance manufacturing site (Lonza, Visp) approved last month. ![]() The CHMP also recommended the approval of a new filling line at Moderna’s finished product manufacturing site for the EU in Rovi, Spain. New filling manufacturing line for COVID-19 vaccine Moderna The changes described will be included in the publicly available information on this vaccine on EMA’s website. EMA’s decision reaffirms that the Puurs facility is capable of consistently producing high-quality vaccines and enables Pfizer/BioNTech to scale up the production process at this site. The recommendation by the Agency’s Committee for Human Medicines ( CHMP) is expected to have a significant impact on the supply of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer, in the European Union.īased on the review of the data submitted by BioNTech Manufacturing GmbH, the application to increase the batch size of the finished product manufactured at the Puurs site has been approved. ![]() Scaled-up processes for BioNTech/Pfizer’s COVID-19 vaccineĮMA has approved an increase in batch size and associated process scale up at Pfizer’s vaccine manufacturing site in Puurs, Belgium. EMA’s human medicines committee ( CHMP) has adopted two important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |